drugset / Trial / NCT07811908
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)
RandomizedParallel-groupOpen-labelTreatment
Summary
This was Cohort C2 of the Platform study (NCT05750628) to evaluate the efficacy and safety of Cipargamin + KLU156 in participants with uncomplicated Plasmodium falciparum malaria.
Timeline
- Start
- 2026-02-12
- Primary completion
- 2027-02-04
- Completion
- 2027-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cipargamin | Small molecule | — | Oral |
| Comparator | Coartem | Unknown | — | Oral |
| Subject | KLU156 | Unknown | — | Oral |